4904-21-6

Basic information

• Product Name: 4-CYCLOPROPYL-PYRIDINE
• Synonyms: 4-CYCLOPROPYL-PYRIDINE
• CAS NO: 4904-21-6
• Molecular Formula: C8H9N
• Molecular Weight: 119.16
• Mol File: 4904-21-6.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-CYCLOPROPYL-PYRIDINE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-CYCLOPROPYL-PYRIDINE(4904-21-6)
• EPA Substance Registry System: 4-CYCLOPROPYL-PYRIDINE(4904-21-6)

Safety Data

• Hazardous Substances Data: 4904-21-6(Hazardous Substances Data)

Usage

Uses

4-Cyclopropylpyridine could be a useful compound for preparing COX-2 inhibitors with anti-pyretic and anti-inflammatory activity.

Upstream product

• 181219-01-2 4-pyridineboronic acid pinacol ester 
• 17228-69-2 2-chloro-4-methoxy-pyridine 
• 411235-57-9 cyclopropylboronic acid 
• 110-86-1 pyridine 
• 59137-44-9 3-carboxy-2-(pyridin-1-ium-1-yl)propanoate 
• 1120-87-2 4-bromopyridin 
• 19524-06-2 4-bromopyridine hydrochloride 
• 2629-72-3 4-(3-Hydroxypropyl)pyridine 
• 35717-98-7 bis(2-propyl)-p-toluenesulfonyloxymethylphosphonate 
• 87748-31-0 3-(pyrid-4'-yl)-2-pyrazo-ine 

Downstream Products

• 1333414-24-6 4-cyclopropylpyridine-2-carbonitrile 
• 1297138-53-4 1-amino-4-cyclopropylpyridin-1-ium 2,4,6-trimethylbenzenesulfonate 

Relevant articles and documents

METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS

The subject matter described herein is directed to ferroportin inhibitor compounds of Formula (I) and pharmaceutical salts thereof, methods of preparing the compounds, pharmaceutical compositions comprising the compounds, and methods of administering the compounds for prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, particularly iron overload states, such as thalassemia, sickle cell disease and hemochromatosis, and also kidney injuries.

INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF

The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.

Synthesis and utility of dihydropyridine boronic esters

When activated by an acylating agent, pyridine boronic esters react with organometallic reagents to form a dihydropyridine boronic ester. This intermediate allows access to a number of valuable substituted pyridine, dihydropyridine, and piperidine products.